Th17 cells in rheumatoid arthritis and systemic lupus erythematosus

Journal of Internal Medicine

Volumn 265, Issue 6, 2009, Pages 644-652

  Pernis, A B ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Interferon regulatory factor 4; IRF 4 binding protein; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS RECEPTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 21; INTERLEUKIN 6; NUCLEAR RECEPTOR RORALPHA; NUCLEAR RECEPTOR RORGAMMAT; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL;

ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 66149120713     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02099.x     Document Type: Conference Paper

References (88)

1. Goodnow CC, Sprent J, de St Groth BF, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005 435 : 590 7. (Pubitemid 40825498)
2. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005 204 : 55 73. (Pubitemid 40460493)
3. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001 1 : 147 53. (Pubitemid 33741968)
4. Tsokos GC, Mitchell JP, Juang Y-T. T cell abnormalities in human and mouse lupus: intrinsic and extrinsic. Curr Opin Rheumatol 2003 15 : 542 7. (Pubitemid 37041390)
5. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008 223 : 87 113.
6. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008 20 : 519 25.
7. Lubberts E. IL-17-Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 2008 41 : 84 91.
8. Seder R, Paul W. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994 12 : 635 73. (Pubitemid 24140427)
9. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006 18 : 349 56.
10. Takatori H, Kanno Y, Chen Z, O'Shea JJ. New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 2008 18 : 533 41.
11. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 32. (Pubitemid 41541790)
12. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005 6 : 1133 41. (Pubitemid 41541791)
13. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005 201 : 233 40. (Pubitemid 40189432)
14. Murphy CA, Langrish CL, Chen Y et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003 198 : 1951 7. (Pubitemid 38032126)
15. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003 171 : 6173 7. (Pubitemid 37467240)
16. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008 453 : 1051 7.
17. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008 8 : 337 48.
18. Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008 453 : 236 40.
19. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008 9 : 641 9.
20. Volpe E, Servant N, Zollinger R et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008 9 : 650 7.
21. Yang L, Anderson DE, Baecher-Allan C et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008 454 : 350 2.
22. Korn T, Bettelli E, Gao W et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007 448 : 484 7. (Pubitemid 47123515)
23. Nurieva R, Yang XO, Martinez G et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007 448 : 480 3. (Pubitemid 47123514)
24. Zhou L, Ivanov II, Spolski R et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007 8 : 967 74. (Pubitemid 47300011)
25. Stritesky GL, Yeh N, Kaplan MH. IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol 2008 181 : 5948 55.
26. Laurence A, Tato CM, Davidson TS et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007 26 : 371 81. (Pubitemid 46413906)
27. Batten M, Li J, Yi S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006 7 : 929 36. (Pubitemid 44263906)
28. Stumhofer JS, Laurence A, Wilson EH et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006 7 : 937 45. (Pubitemid 44263907)
29. Intlekofer AM, Banerjee A, Takemoto N et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008 321 : 408 11.
30. Coquet JM, Chakravarti S, Kyparissoudis K et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci USA 2008 105 : 11287 92.
31. Goto M, Murakawa M, Kadoshima-Yamaoka K et al. Murine NKT cells produce Th17 cytokine interleukin-22. Cell Immunol 2009 254 : 81 4.
32. Takatori H, Kanno Y, Watford WT et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2008 206 : 35 41.
33. Crispin JC, Oukka M, Bayliss G et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008 181 : 8761 6.
34. Schindler C, Strehlow I. Cytokines and STAT signaling. Adv Pharmacol 2000 47 : 113 74.
35. Chen Z, Laurence A, Kanno Y et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 2006 103 : 8137 42. (Pubitemid 43801065)
36. Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007 282 : 34605 10. (Pubitemid 350232469)
37. Yang XO, Panopoulos AD, Nurieva R et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007 282 : 9358 63.
38. O'Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity 2008 28 : 477 87.
39. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK-STAT signalling pathway. Semin Cell Dev Biol 2008 19 : 414 22.
40. Veenbergen S, Bennink MB, de Hooge AS et al. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis. Arthritis Rheum 2008 58 : 3742 52.
41. Wong PK, Egan PJ, Croker BA et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 2006 116 : 1571 81. (Pubitemid 43911011)
42. Yang XO, Pappu BP, Nurieva R et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008 28 : 29 39.
43. Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006 126 : 1121 33. (Pubitemid 44380299)
44. Brustle A, Heink S, Huber M et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007 8 : 958 66. (Pubitemid 47300010)
45. Chen Q, Yang W, Gupta S et al. IRF-4 Binding Protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 2008 29 : 899 911.
46. Matsuyama T, Grossman A, Mittrucker H et al. Molecular cloning of LSIRF, a lymphoid-specific member of the ineterferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res 1995 23 : 2127 36.
47. Rengarajan J, Mowen KA, Mcbride KD, Smith ED, Singh H, Glimcher LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 2002 195 : 1003 12. (Pubitemid 34412002)
48. Gupta S, Lee A, Hu C et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Human Immunol 2003 64 : 389 401. (Pubitemid 36373771)
49. Hotfilder M, Baxendale S, Cross MA, Sablitzky F. Def-2, -3, -6, -8, novel mouse genes differentially expressed in the hematopoietic system. Br J Haematol 1999 106 : 335 44. (Pubitemid 29450655)
50. Tanaka Y, Bi K, Kitamura R, Hong S, Altman Y, Matsumoto A, Tabata H, Lebedeva S, Bushway PJ, Altman A. SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 2003 18 : 403 14. (Pubitemid 36351519)
51. Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2005 11 : S39 44. (Pubitemid 40863818)
52. Koenders MI, Joosten LA, van den Berg WB. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis 2006 65 (Suppl. 3 iii29 33. (Pubitemid 44629098)
53. Stamp LK, James MJ, Cleland LG. Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunol Cell Biol 2004 82 : 1 9. (Pubitemid 38388713)
54. Moreland LW, Curtis JR. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Semin Arthritis Rheum 2008 (in press).
55. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 2005 5 : 688 98. (Pubitemid 43086171)
56. Mehta DS, Wurster AL, Grusby MJ. Biology of IL-21 and the IL-21 receptor. Immunol Rev 2004 202 : 84 95. (Pubitemid 39576906)
57. Chabaud M, Durand JM, Buchs N et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999 42 : 963 70. (Pubitemid 29215007)
58. Lubberts E, Joosten LA, Oppers B et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001 167 : 1004 13. (Pubitemid 32660858)
59. Ziolkowska M, Koc A, Luszczykiewicz G et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000 164 : 2832 8. (Pubitemid 30115519)
60. Koenders MI, Devesa I, Marijnissen RJ et al. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum 2008 58 : 3461 70.
61. Shahrara S, Huang Q, Mandelin AM II., Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008 10 : R93.
62. Kirkham BW, Lassere MN, Edmonds JP et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006 54 : 1122 31. (Pubitemid 43672925)
63. Bush KA, Farmer KM, Walker JS, Kirkham BW. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum 2002 46 : 802 5. (Pubitemid 34214263)
64. Lubberts E, Koenders MI, Oppers-Walgreen B et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004 50 : 650 9. (Pubitemid 38198849)
65. Egan PJ, van Nieuwenhuijze A, Campbell IK, Wicks IP. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis Rheum 2008 58 : 3720 9.
66. Abdollahi-Roodsaz S, Joosten LA, Helsen MM et al. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum 2008 58 : 3753 64.
67. Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med 2008 205 : 2491 7.
68. Fujimoto M, Serada S, Mihara M et al. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 2008 58 : 3710 9.
69. Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA 2008 105 : 14993 8.
70. Young DA, Hegen M, Ma HL et al. Blockade of the interleukin-21- interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 2007 56 : 1152 63. (Pubitemid 46608640)
71. Mamane Y, Sharma S, Graandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T cell leukemogenesis. J Interferon Cytokine Res 2002 22 : 135 43. (Pubitemid 34161291)
72. Habu K, Nakayama-Yamada J, Asano M et al. The human T cell leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice. J Immunol 1999 162 : 2956 63. (Pubitemid 29309324)
73. Roucoux DF, Murphy EL. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 2004 6 : 144 54. (Pubitemid 39599984)
74. Eisenberg R. Mechanisms of autoimmunity. Immunol Res 2003 27 : 203 18. (Pubitemid 36995007)
75. Kong P, Odegard J, Bouzahzah F et al. Intrinsic T cell defects in systemic autoimmunity. Ann N Y Acad Sci 2003 987 : 60 7. (Pubitemid 36584007)
76. Kurasawa K, Hirose K, Sano H et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000 43 : 2455 63.
77. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000 9 : 589 93.
78. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008 127 : 385 93.
79. Kang HK, Liu M, Datta SK. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007 178 : 7849 58. (Pubitemid 46898057)
80. Hsu HC, Yang P, Wang J et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008 9 : 166 75.
81. Wu HY, Quintana FJ, Weiner HL. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells. J Immunol 2008 181 : 6038 50.
82. Sawalha AH, Kaufman KM, Kelly JA et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2008 67 : 458 61.
83. Ozaki K, Spolski R, Ettinger R et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004 173 : 5361 71. (Pubitemid 39392119)
84. Vinuesa CG, Cook MC, Angelucci C et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005 435 : 452 8. (Pubitemid 40734237)
85. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 2007 178 : 3822 30. (Pubitemid 46417651)
86. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005 52 : 1138 47. (Pubitemid 40530121)
87. Criswell LA, Pfeiffer KA, Lum RF et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005 76 : 561 71. (Pubitemid 40432164)
88. Fanzo JC, Yang W, Jang SY et al. Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. J Clin Invest 2006 116 : 703 14. (Pubitemid 43326879)